242648 ⎘
2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#3Methods of treating atopic dermatitis with IL-31 monoclonal antibodies
#4IL-31 monoclonal antibodies
#52,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#6Product and process for liquefaction of mucus or sputum
#7Polynucleotides encoding IL-31 monoclonal antibodies
#82,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
#9TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases
#10Human antibodies that bind human interleukin-12
#11Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same
#12Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23
#13Methods of treatment using human antibodies that bind IL-12
#14AGGREGATES WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN
#15Cytokine antagonists for neurological and neuropsychiatric disorders
#16Aminopterin Dosage Forms and Methods for Inflammatory Disorders
#17Tricyclic compounds, compositions, and methods
#18Methods of treatment using anti-IL-20 antibodies
#19Tricyclic compounds, compositions and methods
#20Triterpene compositions and methods for use thereof
#21Method of reducing pruritis using IL-31 monoclonal antibodies
#22Method for treating a mammal by administration of a compound having the ability to release CO
#23Treatment of autoimmune conditions with Copolymer 1 and related copolymers
#24Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23
#25Tricyclic compounds, compositions and methods
#26Use of lignan compounds for treating or preventing inflammatory disease
#27NOVEL RECEPTOR THAT BINDS CTLA-8
#28Triterpene compositions and methods for use thereof
#29Treatment of inflammation and/or endotoxic shock
#30CYTOKINE ANTAGONISTS FOR NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
#31Method to treat inflammation
#32Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23
#33PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
#34Tricyclic compounds, compositions and methods
#35Compositions Comprising Hypsizygus Ulmarius Extract
#36HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#37Pharmaceutical preparations for treating inflammatory diseases
#38Interleukin-4 receptors
#39Method for treating inflammation
#40Methods of using IL-31 monoclonal antibodies to reduce inflammation
#41Method of inhibiting the emigration of cells from the intravascular compartment into tissues
#42Human Antibodies That Bind Human IL-12 And Methods For Producing
#43AGGREGATES WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN
#44Modulating toll-like receptor activity
#45WOUND AND ULCER TREATMENT WITH SUPER-OXIDIZED WATER
#46Methods of inhibiting interleukin-17 receptor
#47NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY
#48NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY
#49NSAID FORMULATIONS, BASED ON HIGHLY ADAPTABLE AGGREGATES, FOR IMPROVED TRANSPORT THROUGH BARRIERS AND TOPICAL DRUG DELIVERY
#50Tricyclic compounds, compositions, and methods
#51HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#52Topical preparation and method for transdermal delivery and localization of therapeutic agents
#53Compositions comprising extract
#54Compositions and Methods for Treating Burns
#55Fluridone as an anti-inflammatory agent
#56Fatty Acid Modified Forms of Glucocorticoids
#57Tricyclic compound, compositions, and methods
#58METHOD FOR TREATING INFLAMMATION
#59Treatment of infected tissues with hypochlorous acid
#60Aminopterin dosage forms and methods for inflammatory disorders
#61AMINOPTERIN DOSAGE FORMS
#62Product and process for liquefaction of mucus or sputum
#63Protein conjugates with a water-soluble biocompatible, biodegradable polymer
#64Fatty acid modified forms of glucocorticoids
#65Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
#66Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
#67IL-31 monoclonal antibodies
#68Method for treating inflammation
#69Method for treating a mammal by administration of a compound having the ability to release CO
#70Aminopterin dosage forms and methods for inflammatory disorders
#71Treatment of mucosal membranes
#72Estrogenic compounds as anti-mitotic agents
#73Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#74Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents
#75Therapeutic treatments using the direct application of antimicrobial metal compositions
#76Treatment of acne
#77Triterpene compositions and methods for use thereof
#78Cytokine antagonists for neurological and neuropsychiatric disorders
#79Aqueous ionic solutions and their uses in particular in ophthalmology
#80Compositions and methods for treating burns
#81Treatment of inflammatory skin conditions
#82Mucolytic and anti-elastase compounds and methods of use thereof
#83Methods and compositions useful to prevent in-grown hair arising from shaving
#84Method of inhibiting the emigration of cells from the intravascular compartment into tissues
#85Anti-inflammatory activity of a specific turmeric extract
#86Antibodies to Interleukin-4 receptors and uses thereof
#87Methods, compositions and systems for the prevention and treatment of diaper rash
#88Extracellular NAD and cADPR as potent anti-inflammatory agents
#89Compositions comprising thylakoids useful in the modulation of inflammation process
#90Solubility and Absorption Promoter
#91Skin preparation for external use containing frass as the active ingredient
#92Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
#93Bioadhesive antibacterial wound healing composition
#94Human antibodies that bind human IL-12